IPSEF
Price:
$113.13
Market Cap:
$12.94B
Ipsen S.A. is a global biopharmaceutical enterprise specializing in the development and commercialization of therapeutic solutions. The company's focus areas include cancer treatment (oncology), neurological conditions, digestive health (gastroenterology), cognitive impairments, and various rare disorders. Its specialized pharmaceutical portfolio encompasses treatments for oncology and rare disorders, featuring Somatuline (for neuroendocrine tumors and acromegaly), Decapeptyl (for advanced prostate cancer), Cabometyx (for renal cell carcinoma and certain hepatocellular carcinomas), Onivyde (for metastatic pancreatic cancer), Xermelo (for carcinoid syndrome), and Cometriq (for medullary thyro...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-09-21
Stock Exchange
OTC
Ticker
IPSEF
According to Ipsen S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 18.07. This represents a change of 23.40% compared to the average of 14.64 of the last 4 quarters.
The mean historical PE Ratio of Ipsen S.A. over the last ten years is 5.78. The current 18.07 PE Ratio has changed 31.16% with respect to the historical average. Over the past ten years (40 quarters), IPSEF's PE Ratio was at its highest in in the December 2025 quarter at 22.37. The PE Ratio was at its lowest in in the December 2011 quarter at -19.56.
Average
5.78
Median
18.06
Minimum
-119.70
Maximum
30.99
Discovering the peaks and valleys of Ipsen S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.20%
Maximum Annual PE Ratio = 30.99
Minimum Annual Increase = -595.33%
Minimum Annual PE Ratio = -119.70
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 22.16 | -16.32% |
| 2024 | 26.48 | 91.20% |
| 2023 | 13.85 | -0.77% |
| 2022 | 13.96 | 32.47% |
| 2021 | 10.54 | 2.57% |
| 2020 | 10.27 | -108.58% |
| 2019 | -119.70 | -595.33% |
| 2018 | 24.16 | -22.03% |
| 2017 | 30.99 | 23.61% |
| 2016 | 25.07 | -5.46% |
The current PE Ratio of Ipsen S.A. (IPSEF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.83
5-year avg
17.40
10-year avg
5.78
Ipsen S.A.’s PE Ratio is less than IHH Healthcare Berhad (36.74), greater than Universal Health Services, Inc. (5.85), less than Eisai Co., Ltd. (28.54), less than Hangzhou Tigermed Consulting Co., Ltd. (45.08), greater than Lee's Pharmaceutical Holdings Limited (6.86), less than Kaken Pharmaceutical Co., Ltd. (66.91), greater than Adcock Ingram Holdings Limited (12.79), less than Indivior PLC (19.05), less than Indivior PLC (19.05), greater than China Shineway Pharmaceutical Group Limited (5.26),
| Company | PE Ratio | Market cap |
|---|---|---|
| 36.74 | $15.11B | |
| 5.85 | $8.84B | |
| 28.54 | $17.64B | |
| 45.08 | $6.16B | |
| 6.86 | $112.06M | |
| 66.91 | $984.58M | |
| 12.79 | $624.32M | |
| 19.05 | $3.01B | |
| 19.05 | $2.89B | |
| 5.26 | $758.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ipsen S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ipsen S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ipsen S.A.'s PE Ratio?
How is the PE Ratio calculated for Ipsen S.A. (IPSEF)?
What is the highest PE Ratio for Ipsen S.A. (IPSEF)?
What is the 3-year average PE Ratio for Ipsen S.A. (IPSEF)?
What is the 5-year average PE Ratio for Ipsen S.A. (IPSEF)?
How does the current PE Ratio for Ipsen S.A. (IPSEF) compare to its historical average?